Stay updated on Andecaliximab mFOLFOX6 in Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Andecaliximab mFOLFOX6 in Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Andecaliximab mFOLFOX6 in Gastric Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page continues to show a 403 Forbidden error instead of the study record. The footer revision label changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-15T15:46:53.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1 on an otherwise unchanged 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-08T16:15:42.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study record, indicating access is blocked, with the typical ClinicalTrials.gov header and footer shown on the error page.
    Difference
    18%
    Check dated 2026-09-24T19:16:26.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.6 to v3.7.0 on the page, reflecting a newer version of the interface. This is a minor UI/version change and does not modify study data, eligibility criteria, or results.
    Difference
    0.0%
    Check dated 2026-09-17T19:44:01.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.5 to v3.6.6. This indicates a minor administrative update to the site's version metadata rather than changes to study details.
    Difference
    0.0%
    Check dated 2026-09-03T16:58:11.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    A new line '2015 ( U.S. NIH Grant/Contract )' was added to the study's identifiers, indicating NIH funding for GS-US-296-1080.
    Difference
    0.0%
    Check dated 2026-08-27T15:49:35.000Z thumbnail image

Stay in the know with updates to Andecaliximab mFOLFOX6 in Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Andecaliximab mFOLFOX6 in Gastric Cancer Clinical Trial page.